Encouraging Multiple PrEP Options for Women Engaged in PRimary Care
EMPOWER
1 other identifier
interventional
132
1 country
1
Brief Summary
This study will address the significant yet often overlooked problem of HIV among cisgender women. To do this, researchers will adapt and test a multilingual technology-based strategy supporting informed decision-making for PrEP in primary care. Specifically, researchers will use the electronic health record to securely send women multimedia educational materials in English or Spanish about PrEP, and facilitate electronic scheduling of PrEP visits - if women decide they are interested. Choice is critical.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2025
CompletedStudy Start
First participant enrolled
May 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMay 4, 2026
April 1, 2026
9 months
January 15, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PrEP Knowledge
PrEP knowledge is our primary outcome. We will use an adapted version of an existing PrEP knowledge scale by Walsh (2019). Participants will be asked 13 questions, each with true, false or don't know response options. The number of correct answers will be summed and expressed as percentage correct. Higher scores will represent greater PrEP knowledge.
Two to 4 weeks after women are sent materials (attention control or EMPOWER Strategy) in their patient portal accounts
Study Arms (2)
Attention Control
OTHEREMPOWER Strategy
EXPERIMENTALInterventions
The EMPOWER Strategy will: 1) identify women in primary care; 2) deliver understandable, actionable, and non-stigmatizing PrEP education, in multiple formats and languages, directly and securely to women via the patient portal; 3) enable women to discreetly self-schedule a visit to discuss PrEP options via the patient portal, with either their own PCP or with a female PCP who has years of experience in PrEP delivery; and 4) support PCP counseling via clinical decision support that provides standardized, patient-centered language to guide PrEP discussions and via 'smart sets' to facilitate PrEP prescribing, when desired and appropriate.
Women in this arm will be sent, via the patient portal, a CDC patient education material on benefits of physical activity. The material will be in English or Spanish based on patient's language.
Eligibility Criteria
You may qualify if:
- Participants must:
- identify as a cisgender woman
- be aged 18 years or older
- speak English or Spanish
- be a primary care patient at the participating health center
- have an active patient portal account
- be HIV negative
- have never been prescribed PrEP
You may not qualify if:
- Individuals will be excluded if they have any:
- \- severe, uncorrectable vision, hearing, or cognitive impairments that would preclude study consent or participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Stacy C Bailey, PhD, MPH
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 15, 2025
First Posted
January 20, 2025
Study Start
May 19, 2025
Primary Completion
February 19, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- April 2026 for at least 3 years
- Access Criteria
- We will submit de-identified data to the NIMH Data Archive.
All IDP collected throughout the trial will be included.